Dongkook Pharmaceutical signs license and supply agreement for ‘Euresco Tablet’, an improved new drug for benign prostatic hyperplasia, in 13 countries in Central and South America
⚡ Quick Summary
Dongkuk Pharmaceutical signed a license and supply contract for ‘Euresco Tablet’, an improved new drug combination drug for the treatment of benign prostatic hyperplasia.
Dongkuk Pharmaceutical signed a license and supply contract for ‘Euresco Tablet’, an improved new drug combination drug for the treatment of benign prostatic hyperplasia. Dongkuk Pharmaceutical announced on the 1st that it signed a license and supply contract for Euresco Tablet worth a total of 39 billion won for the next 10 years in 13 Central and South American countries, including Mexico, Colombia, and Ecuador, with Spanish global pharmaceutical company FAES FARMA. This contract includes a deposit of up to 2...
🗞️ 1 sources covered this story
📰 Related Articles
Alibaba admits to aiding and abetting illegal drug distribution in the US... Agreement to pay 900 billion won
Yonhap
Culture and Sports Committee pushes for hearings at the Football Association... Looks like Hong Myung-bo and Chung Mong-gyu will be called
Yonhap
Comprehensive special prosecutor "Former Minister of Land, Infrastructure and Transport Won Hee-ryong must appear by the 6th"... summons re-notification
Yonhap
Legislative and Judiciary Committee begins activities in the second half of the year led by Mr. “Supplementary investigation rights related law to be submitted to the state”
Yonhap
Government says 'Coupang discrimination' report to U.S. House of Representatives regrets reflecting one-sided claims
Yonhap